Kevin Kalinsky, MD, MS
@KalinskyKevin
Division Director of Medical Oncology at Winship/Director Glenn Family Breast Center/Opinions=my own
ID:1087816554400698379
https://winshipcancer.emory.edu/bios/faculty/kalinsky-kevin.html 22-01-2019 20:57:32
164 Tweets
1,8K Followers
148 Following
Kevin Kalinsky, MD, MS Sara Tolaney Melinda Telli, M.D. Komal Jhaveri Hope Rugo Aditya Bardia, MD Paolo Tarantino 21/21
đThank you for scrolling down this far, following our conversation, and reinforcing your knowledge of ADC for #breastcancer !
Go online for more CCO education! clinicaloptions.com/BreastTROP2HERâŚ
Thank you to Kevin Kalinsky, MD, MS for this #breastcancer #xtorial 𧾠#MedX
Kevin Kalinsky, MD, MS Sara Tolaney Melinda Telli, M.D. Komal Jhaveri Hope Rugo Aditya Bardia, MD Paolo Tarantino 19/21
đSeveral HER2-directed ADCs are currently in clinical development â˛. #MedX #Xtorial #Tweetorial #MedTwitter
Kevin Kalinsky, MD, MS Sara Tolaney Melinda Telli, M.D. Komal Jhaveri 3/21 T-DXd, SG, and Dato-DXd have been tested in phase III trials. All 3 ADCs inhibit topoisomerase I, but there are slight differences in their cytotoxic payloads. #DESTINY -Breast04 #TROPiCS -02 #TROPIONBreast01
Kevin Kalinsky, MD, MS #medtwitter #tweetorial #Xtorial
Kevin Kalinsky, MD, MS Sara Tolaney Melinda Telli, M.D. Komal Jhaveri Hope Rugo Aditya Bardia, MD Paolo Tarantino 6/21 â Unique toxicities associated with T-DXd include ILD. This is an important AE associated with T-DXd that everyone needs to be aware of so that appropriate and careful monitoring and management are performed.
âTesting for TROP-2 is not necessary when considering SG. TROP-2 is overexpressed across all #breastcancer subtypes but is most elevated in #TNBC . SG is the first and only FDA-approved TROP-2âdirected ADC in the HER2-negative #breastcancer setting.
â join our upcoming #xtorial with Kevin Kalinsky, MD, MS! Dr. Kalinsky, will discuss perspectives on novel and emerging #HER2 directed and #TROP2 targeted ADCs for advanced #BreastCancer !
Tune in this Friday from 9am - 10am EST! We'll be posting right here!
THIS WEEK! Aditya Bardia, MD, Kevin Kalinsky, MD, MS and Lesley Fallowfield will hold a lively and interactive discussion about the use of oral selective estrogen receptor degraders (SERDs) in ER-positive/HER2-negative metastatic breast cancer.
đ Register you interest ms.spr.ly/6018cQWTr
The Champions and Friends of Dunwoody Country Club have given Winship $1 million in new gifts to endow a new professorship in prostate cancer. Winship medical oncologist Mehmet Asim Bilen, MD, (Mehmet Asim Bilen,MD) has been named the inaugural Professor. Learn more: brnw.ch/21wIcKU
Really grateful for this opportunity. Look forward to our continued growth, as we focus on compassionate and equitable care, mentorship, and achieving our academic mission Winship Cancer Institute of Emory University Emory University
SAVE THE DATE - #DDHO2024 is happening July 25 - 28, 2024!
Registration opens next month. Learn more at winshipcancerddho.com.
Sagar Lonial MD Suresh S. Ramalingam, MD, FASCO